Logo image of BFRG

BULLFROG AI HOLDINGS INC (BFRG) Stock Fundamental Analysis

USA - NASDAQ:BFRG - US12021E1091 - Common Stock

1.41 USD
+0.07 (+5.22%)
Last: 10/23/2025, 8:00:01 PM
1.43 USD
+0.02 (+1.42%)
After Hours: 10/23/2025, 8:00:01 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to BFRG. BFRG was compared to 35 industry peers in the Health Care Technology industry. The financial health of BFRG is average, but there are quite some concerns on its profitability. BFRG is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

BFRG had negative earnings in the past year.
BFRG had a negative operating cash flow in the past year.
BFRG had negative earnings in each of the past 5 years.
In the past 5 years BFRG always reported negative operating cash flow.
BFRG Yearly Net Income VS EBIT VS OCF VS FCFBFRG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -2M -4M -6M

1.2 Ratios

BFRG has a Return On Assets of -243.02%. This is amonst the worse of the industry: BFRG underperforms 94.29% of its industry peers.
BFRG has a worse Return On Equity (-318.67%) than 77.14% of its industry peers.
Industry RankSector Rank
ROA -243.02%
ROE -318.67%
ROIC N/A
ROA(3y)-1273.22%
ROA(5y)-2623.94%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BFRG Yearly ROA, ROE, ROICBFRG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -2K -4K

1.3 Margins

With a Gross Margin value of 19.52%, BFRG is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
BFRG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19.52%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BFRG Yearly Profit, Operating, Gross MarginsBFRG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -5K -10K -15K -20K -25K

More info and screens

4

2. Health

2.1 Basic Checks

BFRG does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BFRG has more shares outstanding
There is no outstanding debt for BFRG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BFRG Yearly Shares OutstandingBFRG Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2M 4M 6M 8M
BFRG Yearly Total Debt VS Total AssetsBFRG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M

2.2 Solvency

Based on the Altman-Z score of -4.29, we must say that BFRG is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -4.29, BFRG is doing worse than 74.29% of the companies in the same industry.
BFRG has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of BFRG (0.05) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z -4.29
ROIC/WACCN/A
WACC10.05%
BFRG Yearly LT Debt VS Equity VS FCFBFRG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 2M -2M 4M -4M -6M

2.3 Liquidity

A Current Ratio of 3.97 indicates that BFRG has no problem at all paying its short term obligations.
BFRG has a Current ratio of 3.97. This is amongst the best in the industry. BFRG outperforms 82.86% of its industry peers.
BFRG has a Quick Ratio of 3.97. This indicates that BFRG is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of BFRG (3.97) is better than 82.86% of its industry peers.
Industry RankSector Rank
Current Ratio 3.97
Quick Ratio 3.97
BFRG Yearly Current Assets VS Current LiabilitesBFRG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M

More info and screens

0

3. Growth

3.1 Past

BFRG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.30%, which is quite good.
Looking at the last year, BFRG shows a very negative growth in Revenue. The Revenue has decreased by -52.43% in the last year.
EPS 1Y (TTM)10.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%24.75%
Revenue 1Y (TTM)-52.43%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BFRG Yearly Revenue VS EstimatesBFRG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 20K 40K 60K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

BFRG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BFRG Price Earnings VS Forward Price EarningsBFRG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BFRG Per share dataBFRG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4 -0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

BFRG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BULLFROG AI HOLDINGS INC

NASDAQ:BFRG (10/23/2025, 8:00:01 PM)

After market: 1.43 +0.02 (+1.42%)

1.41

+0.07 (+5.22%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners3.08%
Inst Owner Change-0.27%
Ins Owners23.21%
Ins Owner Change3.59%
Market Cap14.66M
Revenue(TTM)33.30K
Net Income(TTM)-6972800
AnalystsN/A
Price TargetN/A
Short Float %4.11%
Short Ratio2.16
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 440.36
P/FCF N/A
P/OCF N/A
P/B 6.7
P/tB 6.7
EV/EBITDA N/A
EPS(TTM)-0.76
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.55
FCFYN/A
OCF(TTM)-0.55
OCFYN/A
SpS0
BVpS0.21
TBVpS0.21
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -243.02%
ROE -318.67%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 19.52%
FCFM N/A
ROA(3y)-1273.22%
ROA(5y)-2623.94%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.97
Quick Ratio 3.97
Altman-Z -4.29
F-Score3
WACC10.05%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%24.75%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-52.43%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-13.23%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-46.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-46.74%
OCF growth 3YN/A
OCF growth 5YN/A